EBV Infection and Disease Progression Cell-Surface Markers in Latvian Cohort of Untreated Patients with Chronic Lymphocytic Leukemia

Activity: Talk or presentation typesPoster presentation

Description

Epstein Barr virus (EBV) is a human virus implicated in oncogenesis of various lymphomas and associated with autoimmune complications. Previously, we demonstrated that EBV infection of B cells induces expression of the chemokine receptors CCR1 and CCR2. Since 2008, WHO classifies chronic lymphocytic leukemia (CLL), a major type of adult leukemia, as a B-cell NHL. The aim was to assess in untreated CLL patients a relationship between the EBV infection and expression of the cell-surface markers, CCR1, CCR2, and known negative prognostic CD38.. The EBV DNA viral load in PB cells was determined using commercial quantitative PCR kit (detection limit: 5 copies/105 cells). mRNA expression of the EBV latent genes, EBNA2, LMP1, and LMP2A, we also examined. We compared the frequency of the CD38-, CCR1-, and CCR2-expressing PB lymphocyte populations, using multi-parameter flow cytometry, in 23 EBV-positive and 24 EBV-negative untreated CLL patients. The study was funded by the projects: LZP No.lzp-2018/1-0156 and RSU No.6-ZD-22/14/2022.. Three patients only had the high viral load exceeding 200 EBV DNA copies/105 PB cells, two of them were with the moderate frequency and one with >30% of the CD38+ leukemic lymphocytes. The EBV oncogene LMP1 transcription was determined in 3 out of 23 EBV positive patients. Surprisingly, the viral load in these patients was only 6-7 copies/105 cells. The all 3 LMP1-expressing patients were CD38-positive (>30% of CLL cells). In patients co-expressing LMP1 and EBNA2, CCR1 and CCR2 were also presented on >30% of the CD19+CD5+ lymphocytes.. Expression of the EBV oncogene LMP1 in PB cells is linked to expression of the negative prognostic marker CD38 and to the increased number of the CCR1- and CCR2-expressing leukemic cells. CCR1/CCR2 on CLL cells can promote dissemination of these cells through the body thus contributing to progression of the disease.
Period29 Mar 202331 Mar 2023
Event titleRSU International Research Conference 2023: Knowledge for Use in Practice
Event typeConference
OrganiserRīga Stradiņš University
LocationRiga, LatviaShow on map
Degree of RecognitionInternational